AXLA insider filings

Axcella Health Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-03. Screen AXLA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AXLA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Axcella Health Inc.

FiledFormInsiderReported transactionsSource
2023-03-034Koziel Margaret — Chief Medical OfficerSale (S): 679 @ $0.58EDGAR
2023-02-244Koziel Margaret — Chief Medical OfficerGrant/award (A): 70,000 (derivative) @ $0EDGAR
2023-02-244Hinshaw William — President & CEO, DirectorGrant/award (A): 275,000 (derivative) @ $0EDGAR
2023-02-244Fehlner Paul — SVP & Chief Legal OfficerGrant/award (A): 70,000 (derivative) @ $0EDGAR
2023-02-134Fehlner Paul — SVP & Chief Legal OfficerSale (S): 5,221 @ $0.66EDGAR
2022-11-184NISSEN TORBEN STRAIGHT — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-11-184Rosiello Robert L. — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-10-194Hinshaw William — President & CEO, DirectorGrant/award (A): 50,000 · Sale (S): 16,000 @ $1.56EDGAR
2022-10-174Societe des Produits Nestle S.A. — 10% owner
NESTLE SA — 10% owner
Purchase (P): 3,658,536 @ $1.64EDGAR
2022-10-174Flagship Ventures Fund IV General Partner LLC — 10% owner
Flagship Ventures Fund IV, L.P. — 10% owner
Flagship Ventures Opportunities Fund I General Partner LLC — 10% owner
Flagship Ventures Opportunities Fund I, L.P. — 10% owner
AFEYAN NOUBAR — 10% owner
Purchase (P): 2,743,902 @ $1.64 · Purchase (P): 2,757,333 @ $1.64 · Purchase (P): 914,634 @ $1.64 · Purchase (P): 919,111 @ $1.64 · Purchase (P): 3,048,780 @ $1.64EDGAR
2022-09-084Koziel Margaret — Chief Medical OfficerSale (S): 547 @ $2.52EDGAR
2022-06-034Epstein David R — DirectorGrant/award (A): 47,059 @ $0EDGAR
2022-06-024Koziel Margaret — Chief Medical OfficerSale (S): 590 @ $2.01EDGAR
2022-05-254SEKHRI PAUL J — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-05-234Hendrix Martin — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-05-234Rondinone CRISTINA — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-05-234Pisano Gary P. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-05-234Sohn Catherine A. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-05-234Baird William D III — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-05-234Rosenblatt Michael — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-03-214Epstein David R — DirectorOption exercise (M): 1,535 · Grant/award (A): 50,000 (derivative) @ $0 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2022-03-184Hinshaw William — President & CEO, DirectorPurchase (P): 13,089 @ $1.91EDGAR
2022-03-184Fehlner Paul — SVP & Chief Legal OfficerPurchase (P): 10,471 @ $1.91EDGAR
2022-03-184Epstein David R — DirectorPurchase (P): 26,178 @ $1.91EDGAR
2022-03-184Crane Robert — Chief Financial OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2022-03-184Crane Robert — Chief Financial OfficerPurchase (P): 39,267 @ $1.91EDGAR
2022-03-184Flagship Ventures Fund IV General Partner LLC — 10% owner
Flagship Ventures Fund IV, L.P. — 10% owner
Flagship Ventures Fund IV-Rx, L.P. — 10% owner
Flagship Ventures Opportunities Fund I General Partner LLC — 10% owner
Flagship Ventures Opportunities Fund I, L.P. — 10% owner
AFEYAN NOUBAR — 10% owner
Purchase (P): 3,791,623 @ $1.91 · Purchase (P): 947,905 @ $1.91 · Purchase (P): 1,579,843 @ $1.91EDGAR
2022-03-164Societe des Produits Nestle S.A. — 10% owner
NESTLE SA — 10% owner
Purchase (P): 3,141,361 @ $1.91EDGAR
2022-03-034Koziel Margaret — Chief Medical OfficerSale (S): 553 @ $1.86EDGAR
2022-02-234Epstein David R — DirectorOption exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0EDGAR
2022-02-104Schecter Alison D. — President - Research & Dev.Grant/award (A): 56,000 (derivative) @ $0EDGAR
2022-02-104Fehlner Paul — SVP & Chief Legal OfficerGrant/award (A): 70,000 (derivative) @ $0EDGAR
2022-02-104Hinshaw William — President & CEO, DirectorGrant/award (A): 275,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-02-104Koziel Margaret — Chief Medical OfficerGrant/award (A): 33,397 (derivative) @ $0EDGAR
2022-02-104Dean Virginia R — SVP, Chief People OfficerGrant/award (A): 71,400 (derivative) @ $0EDGAR
2022-02-014Hinshaw William — President and CEO, DirectorOption exercise (M): 50,000 · Sale (S): 16,590 @ $1.65 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2022-01-204Epstein David R — DirectorOption exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2021-12-204Epstein David R — DirectorOption exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2021-12-144Schecter Alison D. — President - Research & Dev.Grant/award (A): 25,000 (derivative) @ $0EDGAR
2021-12-134Koziel Margaret — Chief Medical OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2021-11-224Epstein David R — DirectorOption exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0EDGAR
2021-10-194Epstein David R — DirectorOption exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2021-09-204Epstein David R — DirectorOption exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2021-08-254Pisano Gary P. — DirectorOption exercise (M): 81,433 @ $0.28 · Option exercise (M): 81,433 (derivative) @ $0EDGAR
2021-08-194Epstein David R — DirectorOption exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0EDGAR
2021-07-204Epstein David R — DirectorOption exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2021-06-254Dean Virginia R — SVP, Chief People OfficerGrant/award (A): 140,000 (derivative) @ $0EDGAR
2021-06-214Epstein David R — DirectorOption exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2021-05-244Sohn Catherine A. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-05-244Baird William D III — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR

Recent 8-K events — Axcella Health Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-12-228-K7.01 — Regulation FD DisclosureEDGAR
2023-12-198-K2.01 — Completion of Acquisition or Disposition of AssetsEDGAR
2023-12-048-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-11-178-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-11-098-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-11-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-10-068-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
EDGAR
2023-09-188-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-09-148-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-09-118-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AXLA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs